Efficacy of Azacitidine Post-Transplant Maintenance for FLT3-Negative Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引：1
|
作者：
Pasvolsky, Oren [1 ,2 ,3 ]
Saliba, Rima M. [3 ]
Popat, Uday R. [3 ]
Alousi, Amin M. [3 ]
Mehta, Rohtesh S. [3 ]
Yeh, Jason [4 ]
Alatrash, Gheath [3 ]
Masood, Adeel [3 ]
Ramdial, Jeremy L. [3 ]
Rondon, Gabriela [3 ]
Kebriaei, Partow [3 ]
Champlin, Richard E. [3 ]
Shpall, Elizabeth J. [3 ]
Oran, Betul [3 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[2] Rabin Med Ctr, Davidoff Canc Ctr, Inst Hematol, Tel Aviv, Israel
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159336
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10550 / 10551
页数：2
相关论文
共 50 条
  • [1] Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Pasvolsky, Oren
    Saliba, Rima M.
    Popat, Uday R.
    Alousi, Amin
    Mehta, Rohtesh
    Yeh, Jason
    Al-Atrash, Gheath
    Adeel, Masood
    Ramdial, Jeremy
    Marin, David
    Rondon, Gabriela
    Kebriaei, Partow
    Champlin, Richard
    Daver, Naval
    Dinardo, Courtney
    Short, Nicholas J.
    Shpall, Elizabeth J.
    Oran, Betul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : e196 - e204
  • [2] Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia
    Yeh, Jason
    Pasvolsky, Oren
    Saliba, Rima M.
    Figgins, Bradley
    Wang, Christopher
    Fang, Zhou
    Ahmed, Sairah
    Yilmaz, Musa
    Daver, Naval
    Ravandi, Farhad
    Dinardo, Courtney
    Short, Nicholas J.
    Kadia, Tapan
    Al-Atrash, Gheath
    Daher, May
    Costa, David Marin
    Popat, Uday
    Champlin, Richard
    Shpall, Elizabeth
    Oran, Betul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : e819 - e826
  • [3] Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia
    Parks, Katherine
    Aslam, Muhammad Faisal
    Kumar, Vinod
    Jamy, Omer
    CANCERS, 2024, 16 (11)
  • [4] Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome
    Pham, Brian
    Hoeg, Rasmus
    Krishnan, Rajeev
    Richman, Carol
    Tuscano, Joseph
    Abedi, Mehrdad
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 2975 - 2980
  • [5] Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome
    Brian Pham
    Rasmus Hoeg
    Rajeev Krishnan
    Carol Richman
    Joseph Tuscano
    Mehrdad Abedi
    Bone Marrow Transplantation, 2021, 56 : 2975 - 2980
  • [6] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [7] Efficacy and Safety of Gilteritinib Vs. Sorafenib As Post-Transplant Maintenance in Patients with FLT3-ITD Acute Myeloid Leukemia
    Yeh, Jason
    Saliba, Rima M.
    Wang, Christopher
    Fang, Zhou
    Figgins, Bradley
    Ahmed, Sairah
    Yilmaz, Musa
    Daver, Naval
    Mehta, Rohtesh S.
    Alatrash, Gheath
    Marin, David
    Popat, Uday R.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Oran, Betul
    BLOOD, 2022, 140 : 7686 - 7688
  • [8] Post-transplant hypomethylating agent maintenance is associated with a shortened relapse free survival in myelodysplastic syndrome and acute myeloid leukemia
    Byrne, Michael
    Culos, Katie
    Danielson, Nathalie
    Engelhardt, Brian
    Goodman, Stacey
    Mohan, Sanjay
    Prow, Caleb
    Strickland, Stephen
    Chen, Heidi
    Chinratanalab, Wichai
    Gatwood, Katie
    Savani, Bipin
    Sengsayadeth, Salyka
    Kassim, Adetola
    Jagasia, Madan
    BONE MARROW TRANSPLANTATION, 2018, 53 : 358 - 359
  • [9] Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia
    Hirose, Natsuki
    Tachibana, Takayoshi
    Izumi, Akihiko
    Sato, Shuku
    Tadera, Noriyuki
    Tamai, Yotaro
    Kanamori, Heiwa
    Tanaka, Masatsugu
    Nakajima, Hideaki
    HEMATOLOGY, 2023, 28 (01)
  • [10] Pre-transplant mutational burden predicts for post-transplant outcomes in myelodysplastic syndrome and acute myeloid leukemia
    Prendergast, Katherine
    Seegmiller, Adam
    Chen, Heidi
    Chinratanalab, Wichai
    Engelhardt, Brian
    Goodman, Stacey
    Hunt, Carole
    Kassim, Adetola
    Savani, Bipin
    Savona, Michael
    Sengsayadeth, Salyka
    Jagasia, Madan
    Byrne, Michael
    BONE MARROW TRANSPLANTATION, 2018, 53 : 513 - 514
12345